The central hypothesis of this proposal is that the fibrin-rich provisional matrix of normal wounds provides a scaffold for migrating and proliferating cells, and in addition, may directly modulate cell function, may alter cell responsiveness to cytokines, and may act as a reservoir for growth factors or cytokines. We will test two main corollaries of this hypothesis: I. Fibrin matrices regardless of location provide a cytokine- rich milieu that promote cell proliferation and migration. In normal cutaneous wounds, fibrin is deposited in the wound defect and stimulates local fibroplasia and angiogenesis. Healing is the outcome. In chronic venous ulcers, fibrin forms ectopically as cuffs around blood vessels and promotes mesenchymal cell proliferation and neomatrix formation around these vessels. As a consequence, diffusion of oxygen, nutrients, and growth factors to other sites is impeded and healing is impaired. II. Fibrin matrices in venous ulcers differ from normal wound provisional matrix in biochemical structure and molecular content (ECM molecules, cytokines, proteases, protease inhibitors). These differences greatly affect fibroblast function during wound repair. These concepts are not mutually exclusive. We propose to address whether biologic response modifiers associated with fibrin, or the fibrin matrix itself, differs in normal cutaneous wounds and venous leg ulcers. Additionally we will investigate how various fibrin matrices, in the presence or absence of other molecules, affect fibroblast function. Specifically in AIM 1 we will characterize the fibrin-rich matrix and associated mesenchymal cells in normal wounds and venous ulcers.
In AIM 2 we will compare the effects of fibrin matrices of differing composition on fibroblast proliferation.
In AIM 3 we will examine the effects of fibrin matrices of differing composition on fibroblast migration.
In AIM 4 we will determine whether fibrin matrices of differing composition act as reservoirs for growth factors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR042987-02
Application #
2082559
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Project Start
1994-09-30
Project End
1998-08-31
Budget Start
1995-09-01
Budget End
1996-08-31
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
State University New York Stony Brook
Department
Dermatology
Type
Schools of Medicine
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Lin, Fubao; Ren, Xiang-Dong; Doris, Greiling et al. (2005) Three-dimensional migration of human adult dermal fibroblasts from collagen lattices into fibrin/fibronectin gels requires syndecan-4 proteoglycan. J Invest Dermatol 124:906-13
Clark, Richard A F; Lin, Fubao; Greiling, Doris et al. (2004) Fibroblast invasive migration into fibronectin/fibrin gels requires a previously uncharacterized dermatan sulfate-CD44 proteoglycan. J Invest Dermatol 122:266-77
Clark, Richard A F; An, Jian-Qiang; Greiling, Doris et al. (2003) Fibroblast migration on fibronectin requires three distinct functional domains. J Invest Dermatol 121:695-705
Kubo, M; Van de Water, L; Plantefaber, L C et al. (2001) Fibrinogen and fibrin are anti-adhesive for keratinocytes: a mechanism for fibrin eschar slough during wound repair. J Invest Dermatol 117:1369-81
Clark, R A (2001) Fibrin and wound healing. Ann N Y Acad Sci 936:355-67
Tonnesen, M G; Feng, X; Clark, R A (2000) Angiogenesis in wound healing. J Investig Dermatol Symp Proc 5:40-6
Feng, X; Clark, R A; Galanakis, D et al. (1999) Fibrin and collagen differentially regulate human dermal microvascular endothelial cell integrins: stabilization of alphav/beta3 mRNA by fibrin1. J Invest Dermatol 113:913-9
Gailit, J; Clarke, C; Newman, D et al. (1997) Human fibroblasts bind directly to fibrinogen at RGD sites through integrin alpha(v)beta3. Exp Cell Res 232:118-26
Greiling, D; Clark, R A (1997) Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J Cell Sci 110 ( Pt 7):861-70
McClain, S A; Simon, M; Jones, E et al. (1996) Mesenchymal cell activation is the rate-limiting step of granulation tissue induction. Am J Pathol 149:1257-70